Shi Z, Fujii K, Kovary KM, Genuth NR, Röst HL, Teruel MN, Barna M.
2017.
Heterogeneous Ribosomes Preferentially Translate Distinct Subpools of mRNAs Genome-wide.. Mol Cell. 67(1):71-83.e7.
Stone A, Friedman DNovetsky, Worgall S, Kushner BH, Wolden SL, Modak S, LaQuaglia MP, Wu X, Cheung N-K, Sklar CA.
2017.
Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma.. J Pediatr Hematol Oncol. 39(7):547-554.
Rajappa P, Cobb WS, Vartanian E, Huang Y, Daly LA, Hoffman C, Zhang J, Shen B, Yanowitch R, Garg K et al..
2017.
Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells.. Clin Cancer Res. 23(12):3109-3119.
Zeng MY, Inohara N, Nuñez G.
2017.
Mechanisms of inflammation-driven bacterial dysbiosis in the gut.. Mucosal Immunol. 10(1):18-26.
Hoshino A, Lyden DC.
2017.
Metastasis: Lymphatic detours for cancer.. Nature. 546(7660):609-610.
Jourde-Chiche N, Whalen E, Gondouin B, Speake C, Gersuk V, Dussol B, Burtey S, Pascual V, Chaussabel D, Chiche L.
2017.
Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis.. Rheumatology (Oxford). 56(3):477-487.
Cepika A-M, Banchereau R, Segura E, Ohouo M, Cantarel B, Goller K, Cantrell V, Ruchaud E, Gatewood E, Nguyen P et al..
2017.
A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis.. J Exp Med. 214(11):3449-3466.
Arostegui JI, Anton J, Calvo I, Robles A, Iglesias E, López-Montesinos B, Banchereau R, Hong S, Joubert Y, Junge G et al..
2017.
Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.. Arthritis Rheumatol. 69(8):1679-1688.
Sansone P, Savini C, Kurelac I, Chang Q, Amato LBenedetta, Strillacci A, Stepanova A, Iommarini L, Mastroleo C, Daly LA et al..
2017.
Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.. Proc Natl Acad Sci U S A. 114(43):E9066-E9075.
Becher OJ, Gilheeney SW, Khakoo Y, Lyden DC, Haque S, De Braganca KC, Kolesar JM, Huse JT, Modak S, Wexler LH et al..
2017.
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.. Pediatr Blood Cancer. 64(7)
Becher OJ, Millard NE, Modak S, Kushner BH, Haque S, Spasojevic I, Trippett TM, Gilheeney SW, Khakoo Y, Lyden DC et al..
2017.
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.. PLoS One. 12(6):e0178593.
Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RNatasha, Bromberg JF, Kang Y et al..
2017.
Pre-metastatic niches: organ-specific homes for metastases.. Nat Rev Cancer. 17(5):302-317.
Huang Y, Rajappa P, Hu W, Hoffman C, Cisse B, Kim J-H, Gorge E, Yanowitch R, Cope W, Vartanian E et al..
2017.
A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma.. J Clin Invest. 127(5):1826-1838.